Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Synthesis of New-to-Nature Atropopeptides by SNAr Macrocyclization for Medicinal Chemistry

Objective

Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a large and diverse class of natural products that are fundamental to current drug discovery and development. Most of these peptides contain at least one macrocycle and many bear a stereogenic axis on a tryptophan motif, giving rise to atropisomeric macrocyclic peptides. Atropisomers are intrinsically non-planar, bearing shapes that often minimize the entropic penalty upon their binding to biological receptors, often enhancing potency, selectivity or metabolic stability. Nonetheless, drug discovery efforts have been hampered by lack of synthesis methods toward these peptidic atropisomeric molecules. For instance, there is currently no method for peptide macrocyclization toward C–N atropopeptides directly carried out on the indole of tryptophan. Accordingly, in RIPP-SNAr I will develop the first examples of such peptide macrocyclizations, taking advantage of catalytic nucleophilic aromatic substitution (SNAr). The main advantages are: 1) easy access to starting materials; 2) high modularity allowing for incorporation of structural diversity and 3) several possibilities for controlling atroposelective and atropodiastereodivergency. RIPP-SNAr will therefore provide more sustainable organic synthesis and, because new molecules will be tested biologically, may lead to new anticancer or antibacterial entities. My previous experience in synthesis and medicinal chemistry, acquired as PhD student in the United States, will be relevant to the realization of the project; the hallmark of RIPP-SNAr is the symbiosis between my previous experience in synthesis and medicinal chemistry with the experience in stereoselective catalysis from the host group, inserted at IOCB Prague with its long tradition on such interdisciplinary research. This fellowship will ensure that I become a strong candidate for a leadership position in the pharmaceutical industrial sector.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

USTAV ORGANICKE CHEMIE A BIOCHEMIE, AV CR, V.V.I.
Net EU contribution
€ 191 918,16
Address
FLEMINGOVO NAM. 542/2
166 10 PRAHA 6
Czechia
Region
Česko Praha Hlavní město Praha
Activity type
Research Organisations
Links
Total cost
No data